IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,866,144 | +89.2% | 387,240 | -6.5% | 0.00% | +100.0% |
| Q2 2023 | $7,856,312 | +30.4% | 414,144 | +6.6% | 0.00% | 0.0% |
| Q1 2023 | $6,025,123 | -12.2% | 388,467 | +0.5% | 0.00% | 0.0% |
| Q4 2022 | $6,863,109 | +303.2% | 386,654 | +26.8% | 0.00% | +100.0% |
| Q3 2022 | $1,702,000 | +42.9% | 304,975 | -0.1% | 0.00% | – |
| Q2 2022 | $1,191,000 | -27.5% | 305,132 | +2.4% | 0.00% | – |
| Q1 2022 | $1,643,000 | -33.7% | 298,115 | +2.5% | 0.00% | -100.0% |
| Q4 2021 | $2,479,000 | +5.9% | 290,932 | +8.0% | 0.00% | 0.0% |
| Q3 2021 | $2,341,000 | -33.8% | 269,378 | -19.5% | 0.00% | 0.0% |
| Q2 2021 | $3,535,000 | -33.5% | 334,436 | +0.9% | 0.00% | -50.0% |
| Q1 2021 | $5,318,000 | -62.1% | 331,487 | +9.1% | 0.00% | -66.7% |
| Q4 2020 | $14,032,000 | +60.4% | 303,774 | +22.2% | 0.01% | +50.0% |
| Q3 2020 | $8,748,000 | +130.7% | 248,593 | +59.7% | 0.00% | +100.0% |
| Q2 2020 | $3,792,000 | – | 155,703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 1,439,544 | $27,308,150 | 8.29% |
| Logos Global Management LP | 2,250,000 | $42,682,500 | 5.80% |
| Deep Track Capital, LP | 5,421,330 | $102,842,630 | 4.76% |
| TCG Crossover Management, LLC | 654,853 | $12,422,561 | 2.04% |
| COMMODORE CAPITAL LP | 900,000 | $17,073,000 | 1.92% |
| ACUTA CAPITAL PARTNERS, LLC | 141,755 | $2,689,092 | 1.82% |
| Affinity Asset Advisors, LLC | 260,000 | $4,932,200 | 1.72% |
| HighVista Strategies LLC | 180,320 | $3,420,670 | 1.56% |
| Redmile Group, LLC | 1,921,152 | $36,444,253 | 1.40% |
| Perceptive Advisors | 2,523,783 | $47,876,164 | 1.39% |